BARDA Ventures — Equity Co-Investment
Invests in healthcare-focused countermeasure enterprises through BARDA Ventures, advancing diagnostics, vaccines, and resilient production growth stages.
BARDA Ventures is an equity co-investment program operated jointly by the Biomedical Advanced Research and Development Authority and GHIC (Global Health Investment Corporation). It applies venture capital practices — primarily equity investment rather than grants or contracts — to accelerate companies developing transformative medical countermeasures across the full health security chain. Investme…
Transformative medical countermeasure companies from seed through growth stage, spanning disease forecasting, rapid diagnostics, vaccines, therapeutics, resilient domestic manufacturing, and equitable MCM access.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline